日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NAD(+) controls circadian rhythmicity during cardiac aging

NAD(+)在心脏衰老过程中控制昼夜节律。

Carpenter, Bryce J; Lecacheur, Margaux; Mangold, Yannick N; Cui, Kai; Günther, Stefan; Vermunt, Marit W; Dierickx, Pieterjan

Circadian rhythms in cardiovascular (dys)function: approaches for future therapeutics

心血管(功能)紊乱中的昼夜节律:未来治疗策略

Lecacheur, Margaux; Ammerlaan, Daniëlle J M; Dierickx, Pieterjan

PIP4K2B is mechanoresponsive and controls heterochromatin-driven nuclear softening through UHRF1

PIP4K2B 具有机械响应性,可通过 UHRF1 控制异染色质驱动的核软化

Alessandro Poli, Fabrizio A Pennacchio, Andrea Ghisleni, Mariagrazia di Gennaro, Margaux Lecacheur, Paulina Nastały, Michele Crestani, Francesca M Pramotton, Fabio Iannelli, Galina Beznusenko, Alexander A Mironov, Valeria Panzetta, Sabato Fusco, Bhavwanti Sheth, Dimos Poulikakos, Aldo Ferrari, Nils

Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma

靶向盘状结构域受体 DDR1 和 DDR2 可克服黑色素瘤中基质介导的肿瘤细胞适应和对 BRAF 靶向治疗的耐受性

Ilona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, Serena Diazzi, Christopher Rovera, Virginie Prod'homme, Mickael Ohanna, Ana Popovic, Aude Mallavialle, Frédéric Larbret, Sabrina Pisano, Stéphane Audebert, Thierry Passeron, Cédric Gaggioli, Christophe A Girard, Marcel Deckert #, Sophie Tart

Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma

阻断 miR-143/-145 簇介导的促纤维化反应可增强黑色素瘤靶向治疗的疗效。

Diazzi, Serena; Baeri, Alberto; Fassy, Julien; Lecacheur, Margaux; Marin-Bejar, Oskar; Girard, Christophe A; Lefevre, Lauren; Lacoux, Caroline; Irondelle, Marie; Mounier, Carine; Truchi, Marin; Couralet, Marie; Ohanna, Mickael; Carminati, Alexandrine; Berestjuk, Ilona; Larbret, Frederic; Gilot, David; Vassaux, Georges; Marine, Jean-Christophe; Deckert, Marcel; Mari, Bernard; Tartare-Deckert, Sophie